Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil fMRI Study in Healthy Older Adults at Genetic Risk for Alzheimer's Disease
NCT02087865Phase 4Completed
- Sponsor
- Cleveland Clinic
- Start
- May 2014
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of donepezil in Alzheimer's disease (AD), sponsored by Cleveland Clinic. Started May 2014; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02087865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087865.